As filed with the Securities and Exchange Commission on March 25, 2022
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
________________________________________
2seventy bio, Inc.
(Exact name of registrant as specified in its charter)
________________________________________
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| Delaware | | 86-3658454 |
(State or other jurisdiction
of incorporation or organization) | | (I.R.S. Employer
Identification No.) |
2seventy bio, Inc. 60 Binney Street Cambridge, MA (339) 499-9300 (Address of Principal Executive Offices) | | 02142 (Zip Code) |
2021 Stock Option and Incentive Plan
2021 Employee Stock Purchase Plan
(Full title of the plan)
________________________________________
Nick Leschly
President and Chief Executive Officer
2seventy bio, Inc.
60 Binney St.
Cambridge, MA 02142
(339) 499-9300
(Name and address of agent for service)
Copy to:
Michael H. Bison, Esq.
Gregg L. Katz, Esq.
Yasin E. Akbari, Esq.
Goodwin Procter LLP
100 Northern Avenue
Boston, Massachusetts 02210
(617) 570-1000
________________________________________
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, small reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “small reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| | Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
STATEMENT OF INCORPORATION BY REFERENCE
This Registration Statement on Form S-8 relating to the 2021 Stock Option and Incentive Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (the “2021 ESPP”) of 2seventy bio, Inc. (the “Registrant”) is being filed for
the purpose of registering additional securities of the same class as other securities for which a Registration
Statement on Form S-8 has previously been filed and is effective. Accordingly, this Registration Statement incorporates by reference the contents of the registration statement on Form S-8, File No.: 333-260669, filed by the Registrant on November 1, 2021, relating to the 2021 Plan and 2021 ESPP pursuant to General Instruction E.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
See the Exhibit Index for a list of exhibits filed as part of this registration statement, which Exhibit Index is incorporated herein by reference.
EXHIBIT INDEX
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| Exhibit No. | | Description |
| | |
| | |
| | |
| | |
| | |
| | |
| 24.1 | | Power of attorney (included on signature page). |
| | |
| | |
| | |
__________
*Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth of Massachusetts, on the 25th day of March, 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | |
| 2seventy bio, Inc. |
| | |
| By: | /s/ Nick Leschly |
| | Nick Leschly |
| | President and Chief Executive Officer |
POWER OF ATTORNEY
We, the undersigned officers and directors of 2seventy bio, Inc., hereby severally constitute and appoint Nick Leschly and William D. Baird III, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign for us and in our names in the capacities indicated below any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities indicated below on the 25th day of March, 2022.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| Name | | Title | | |
| | | |
| /s/ Nick Leschly | | President, Chief Executive Officer and Director | | |
| Nick Leschly | | (Principal Executive Officer) | | |
| | | |
| /s/ William D. Baird III | | Chief Financial Officer | | |
| William D. Baird III | | (Principal Financial Officer and Principal Accounting Officer) | | |
| | | |
| /s/ Daniel S. Lynch | | Director | | |
| Daniel S. Lynch | | | | |
| | | |
| /s/ Sarah Glickman | | Director | | |
| Sarah Glickman | | | | |
| | | |
| /s/ Ramy Ibrahim | | Director | | |
| Ramy Ibrahim, M.D. | | | | |
| | | |
| /s/ Denice Torres | | Director | | |
| Denice Torres | | | | |
| | | |
| /s/ Marcela Maus | | Director | | |
| Marcela Maus, M.D., Ph.D. | | | | |
| | | |
| /s/ William R. Sellers | | Director | | |
| William R. Sellers, M.D. | | | | |
